Navigation Links
Joslin researchers identify important factor in fat storage and energy metabolism
Date:1/6/2013

BOSTON January 8, 2013 -- As part of their ongoing research on the physiologic factors that contribute to the development of obesity, Joslin Diabetes Center scientists have identified a cell cycle transcriptional co-regulator TRIP-Br2 that plays a major role in energy metabolism and fat storage. This finding has the potential to lead to new treatments for obesity. The study is being published today ahead of print by Nature Medicine.

Transcriptional co-regulators manage the expression of DNA, either by activating or suppressing the expression of genes. TRIP-Br2 regulates metabolic genes involved in fat storage and energy metabolism. Joslin scientists are actively involved in studying the regulation of the many factors that control the storage, mobilization and utilization of excess energy in adipocytes (fat cells).

The scientists looked at TRIP-Br2 levels in mice fed a low-fat diet and a high-fat diet as well as obese mice: the mice on the high-fat diet and the obese mice had higher levels of TRIP-Br2 in their fat tissue. They also found that TRIP-Br2 is significantly elevated in the visceral fat (the fat that accumulates around the middle of the body which has more harmful effects than fat in other areas of the body) of obese people, especially those who store fat mostly in that area.

To illuminate the physiological role of TRIP-Br2 on fat storage and metabolism, the scientists conducted experiments on mice genetically engineered not to produce TRIP-Br2, known as KO (knock out) mice, which were fed either a low-fat diet or a high-fat diet. The KO mice on the high-fat diet showed little change in their body weights, which were similar to the KO mice on the low-fat diet. The KO mice had higher energy expenditure due to increased heat production and increased oxygen consumption. In addition, the KO mice on the high-fat diet had improved glucose tolerance and insulin sensitivity and lower triglycerides.

When TRIP-Br2 is suppressed, the expression of hormone sensitive lipase (HSL) and Beta3-adrenergic (Adrb3) receptors, which are involved in fat breakdown (lipolysis), is significantly enhanced in fat tissue. When TRIP-Br2 is elevated by obesity and a high-fat diet, it suppresses HSL and Adrb3 receptors resulting in a decrease in energy expenditure and an increase in fat accumulation.

"TRIP-Br2 is important for the accumulation of fat," says lead author Rohit N. Kulkarni, M.D., Ph.D., Principal Investigator in the Section on Islet Cell and Regenerative Biology and Associate Professor of Medicine at Harvard Medical School. "When an animal lacks TRIP-Br2, it can't accumulate fat."

TRIP-Br2 modulates fat storage by simultaneously regulating lipolysis, energy output and oxidative metabolism -- which work together as complementary processes. "This is the first study to identify a cell cycle transcriptional co-regulator that controls these processes. TRIP-Br2 appears to have a different mechanism of action than transcriptional co-regulators reported in previous studies," says Dr. Kulkarni.

TRIP-Br2 is a potential therapeutic target to treat obesity and its related complications, including insulin resistance. The Joslin scientists are currently investigating ways to "reduce TRIP-Br2 in visceral fat, which would allow enhanced expression of HSL and Adrb3 receptors. The ability to modify these two molecules offers a new pathway for combating obesity," says Dr. Kulkarni.

Dr. Kulkarni and his colleagues are also investigating whether the suppression of TRIP-Br2 and the resulting resistance to obesity have an impact on the development of cardiovascular disease and metabolic complications.


'/>"/>

Contact: Jeffrey Bright
jeffrey.bright@joslin.harvard.edu
Joslin Diabetes Center
Source:Eurekalert  

Related biology news :

1. Joslin researchers gain new understanding of diabetes and kidney disease
2. Joslin researchers increase understanding of genetic risk factor for type 1 diabetes
3. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
4. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
5. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
6. UNH researchers find African farmers need better climate change data to improve farming practices
7. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
8. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
9. Researchers print live cells with a standard inkjet printer
10. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
11. Researchers reveal how a single gene mutation leads to uncontrolled obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Joslin researchers identify important factor in fat storage and energy metabolism
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
Breaking Biology News(10 mins):
(Date:1/14/2017)...  The Alliance for Safe Biologic Medicines (ASBM) today ... final guidance on biologic naming: We ... the importance of distinct naming for all biologics, including ... biosimilars will bring to patients, including new treatment options ... of the Guidance dealing with suffix design remains at ...
(Date:1/13/2017)... 2017 Research and Markets has announced the addition ... ... to grow at a CAGR of 16.83% during the period 2017-2021. ... of the global biopolymers market for 2017-2021. To calculate the market size, ... biopolymer products. The report also includes a a discussion of the key ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... demand that it has found among its diverse customer base. The latest entry ... in most brands electroporators including BTX and Bio-Rad. FireflySci is introducing three distinct ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... , VTI, Vertebral Technologies, Inc., announces the successful outcome of the first ... September 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product ...
Breaking Biology Technology: